ReviewFrontiers in oncology2022

Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review.

Ran Ran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.